AstraZeneca plc vs Mattel Inc — how do they compare? AstraZeneca plc trades at $158.15 (market cap $248.14B), while Mattel Inc trades at $15.03 (market cap $4.30B). The key difference: AstraZeneca plc is far larger — about 57.7× Mattel Inc's market cap, and AstraZeneca plc pays a 2.01% dividend while Mattel Inc pays none. Which is the better fit depends on your goals.
| AZN | MAT | |
|---|---|---|
Market Cap | $248.14B | $4.30B |
Sector | Health | Consumer Cyclical |
52-Week High | $209.48 | $22.16 |
52-Week Low | $147.06 | $13.05 |
Enterprise Value | $275.41B | $6.52B |
Dividend Yield | 2.01% | — |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Mattel markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, handheld and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Just over half of its net sales are in North America, while the remainder stem from international markets.
Read more on MAT →